Company profile
Cerca Magnetics Limited
Cerca OPM-MEG Home
The Cerca OPM-MEG system is the worlds most advanced functional brain scanner an integrated lightweight, ergonomic and wearable device that will offer an unparalleled window on human brain function, in health and disease.
Corporate ownership
Updated 06 Jun 2026 16:52
Latest accounts
Financial period: 1 Jan 2024 to 31 Dec 2024
Company events
Reference milestones and recent Companies House filing stream events.
Confirmation statement due
Confirmation DueNext confirmation statement due date
Accounts due
Accounts DueNext accounts due date
Confirmation Statement With Updates
Confirmation-statementCS01 | Transaction MzUxNTM0NDI1NWFkaXF6a2N4
Published 10 Apr 2026 08:58
Confirmation statement filed
ConfirmationLast confirmation statement made up date
Capital Alter Shares Subdivision
CapitalSH02 | Transaction MzUxMjgxOTk0MWFkaXF6a2N4 | Paper/PDF filed
Published 08 Apr 2026 14:09
Capital Allotment Shares
CapitalSH01 | Transaction MzUxMjgxOTE2N2FkaXF6a2N4
Published 26 Mar 2026 19:25
Capital Name Of Class Of Shares
CapitalSH08 | Transaction MzUxMDQ0NzY5OWFkaXF6a2N4 | Paper/PDF filed
Published 27 Mar 2026 01:52
Legacy
MiscellaneousANNOTATION | Transaction MzUxMjU1NzcxNGFkaXF6a2N4 | Paper/PDF filed
Published 25 Mar 2026 15:48
Capital Alter Shares Reconversion
CapitalSH02 | Transaction MzUwNTU3NTAwM2FkaXF6a2N4 | Paper/PDF filed
Published 25 Mar 2026 15:46
Accounts filed
AccountsLast accounts made up date
Incorporated
InceptionCompany registered at Companies House
Spinout profile
Company description
Cerca Magnetics develops brain scanning technology, specialising in wearable technology, for treating a range of neurological and psychiatric conditions.
Cerca magnetics build and sell equipment for human brain imaging
SME commercialising OPM MEG technology, developing OPM MEG systems for the research markets in the near term and driving the development of clinical systems for sale into the clinical market in the coming years.
Project impact
Cerca magnetics have spread novel human brain imaging technology, developed in the UK, to labs worldwide. Sales to date (between company launch in Dec 2020 and 2nd March 2023 total >£9M
First confirmed orders in excess of £1,000,000 achieved within 6 months of company creation.
Cerca magnetics have spread novel human brain imaging technology, developed in the UK, to labs worldwide. Sales to date (between company launch in Dec 2020 and 2nd March 2023 total £7.2M
Public funding
Projects
Quantum-Enabled Brain Imaging: A Pathway to Clinical Utility
1 Jan 2024 to 31 Mar 2025
In this project, we will realise the potential of quantum technology for diagnosing and managing treatment of dementia. OPM-MEG is a new type of brain scan that uses quantum sensors to measure the tiny magnetic fields generated by the brain. In this way, OPM-MEG assesses electrical currents flowing through brain cells, and provides assessment of brain act...
Quantum-Enabled Brain Imaging: A Pathway to Clinical Utility
1 Sep 2023 to 30 Nov 2023
Our aim is to harness the potential of quantum technology in healthcare, by introducing a new type of scanner which has the potential to significantly impact human brain health. The human brain, and the disorders that affect it, represent an enormous challenge for 21st century healthcare. From diseases that strike in childhood, like epilepsy, to problems ...
Clinical deployment of wearable functional neuroimaging
1 Feb 2023 to 31 Jan 2026
Understanding the human brain, and the many disorders that affect it, is a major challenge for 21st century healthcare. Significant progress has been made by scanning technologies, like MRI, which show what the brain looks like in exquisite detail. However, in many disorders brain structure looks normal and conventional imaging is of limited use. Instead,...
Brain Imaging Using OPM-MEG: Newborn to Toddler
1 Oct 2021 to 31 Mar 2022
Medical imaging technologies, like MRI, have revolutionised healthcare. Modern scanners can image the structure of organs with millimetre precision, allowing things like growths or tumours to be pinpointed. This information is used by healthcare practitioners for everything from diagnosis to surgical planning. However, despite the success, the current gen...